- Filed
- Nov 7, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2024 · Nov 1, 2024 | 25.64M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2024 | 25.77M sh |
| Shares Diluted | Q3 2024 · Sep 30, 2024 | 25.2M sh |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 1.08M sh |
| Shares Diluted restated | Q3 2024 · Sep 30, 2023 | 994K sh |
| Stock Repurchased | Q3 2024 · Sep 30, 2024 | $1K |
| Stock Repurchased | Q3 2024 · Sep 30, 2023 | $0 |
| Capex | Q3 2024 · Sep 30, 2024 | $0 |
| Capex restated | Q3 2024 · Sep 30, 2023 | $54K |
| Operating Cash Flow | Q3 2024 · Sep 30, 2024 | −$56.37M |
| Operating Cash Flow restated | Q3 2024 · Sep 30, 2023 | −$18.73M |
| Cash And Equivalents | Q3 2024 · Sep 30, 2024 | $35.01M |
| Cash And Equivalents | Q3 2024 · Dec 31, 2023 | $140.73M |
| Cash And Equivalents restated | Q3 2024 · Sep 30, 2023 | $78.04M |
| Stockholders Equity | Q3 2024 · Sep 30, 2024 | $321.07M |
| Stockholders Equity | Q3 2024 · Jun 30, 2024 | $338.28M |
| Stockholders Equity | Q3 2024 · Mar 31, 2024 | $354.16M |
| Stockholders Equity | Q3 2024 · Dec 31, 2023 | $205.04M |
| Stockholders Equity restated | Q3 2024 · Sep 30, 2023 | −$47.41M |
| Stockholders Equity restated | Q3 2024 · Jun 30, 2023 | −$42.53M |
| Stockholders Equity restated | Q3 2024 · Mar 31, 2023 | −$26.84M |
| Stockholders Equity restated | Q3 2024 · Dec 31, 2022 | −$19.73M |
| Current Liabilities | Q3 2024 · Sep 30, 2024 | $7.28M |
| Current Liabilities | Q3 2024 · Dec 31, 2023 | $5M |
| Total Liabilities | Q3 2024 · Sep 30, 2024 | $7.38M |
| Total Liabilities | Q3 2024 · Dec 31, 2023 | $5.25M |
| Current Assets | Q3 2024 · Sep 30, 2024 | $293.79M |
| Current Assets | Q3 2024 · Dec 31, 2023 | $208.87M |
| Total Assets | Q3 2024 · Sep 30, 2024 | $328.45M |
| Total Assets | Q3 2024 · Dec 31, 2023 | $210.3M |
| Eps Diluted | Q3 2024 · Sep 30, 2024 | −$0.78 |
| Eps Diluted | Q3 2024 · Sep 30, 2024 | −$2.02 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$5.16 |
| Eps Diluted restated | Q3 2024 · Sep 30, 2023 | −$29.40 |
| Eps Basic | Q3 2024 · Sep 30, 2024 | −$0.78 |
| Eps Basic | Q3 2024 · Sep 30, 2024 | −$2.02 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$5.16 |
| Eps Basic restated | Q3 2024 · Sep 30, 2023 | −$29.40 |
| Sga Expense | Q3 2024 · Sep 30, 2024 | $5.11M |
| Sga Expense | Q3 2024 · Sep 30, 2024 | $17.49M |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $2.88M |
| Sga Expense restated | Q3 2024 · Sep 30, 2023 | $6.17M |
| Rd Expense | Q3 2024 · Sep 30, 2024 | $19.33M |
| Rd Expense | Q3 2024 · Sep 30, 2024 | $46.44M |
| Rd Expense restated | Q3 2024 · Sep 30, 2023 | $3.76M |
| Rd Expense restated | Q3 2024 · Sep 30, 2023 | $24.35M |
| Net Income | Q3 2024 · Sep 30, 2024 | −$20.18M |
| Net Income | Q3 2024 · Sep 30, 2024 | −$50.98M |
| Net Income | Q3 2024 · Jun 30, 2024 | −$17.49M |
| Net Income | Q3 2024 · Mar 31, 2024 | −$13.31M |
| Net Income restated | Q3 2024 · Sep 30, 2023 | −$5.59M |
| Net Income restated | Q3 2024 · Sep 30, 2023 | −$29.22M |
| Net Income restated | Q3 2024 · Jun 30, 2023 | −$16.13M |
| Net Income restated | Q3 2024 · Mar 31, 2023 | −$7.5M |
| Operating Income | Q3 2024 · Sep 30, 2024 | −$24.44M |
| Operating Income | Q3 2024 · Sep 30, 2024 | −$63.93M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$6.64M |
| Operating Income restated | Q3 2024 · Sep 30, 2023 | −$30.52M |